Below are the top 5 healthcare stocks on the NYSE in terms of ROE.
GlaxoSmithKline plc GSK has a trailing-twelve-month ROE of 61.29%. GSK’s trailing-twelve-month operating margin stands at 33.35%.
Eli Lilly & Company LLY has a trailing-twelve-month ROE of 46.9%. LLY slipped 6.90% over the past 52 weeks, while the S&P 500 rose 13.27% over the same period.
AstraZeneca PLC AZN has a trailing-twelve-month ROE of 45.15%. AZN’s trailing-twelve-month operating margin stands at 40.27%.
Alcon Inc ACL has a trailing-twelve-month ROE of 36.78%. The trailing-twelve-month profit margin of ACL stands at 31.63%.
Novo Nordisk A/S NVO has a trailing-twelve-month ROE of 35.46%. NVO’s quarterly earnings grew by 23.20% year-over-year.
Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: EarningsLong IdeasNewsMarketsTrading IdeasHealth CareHealth Care SuppliesHealthcare Sectorhighest return on equitylarge-cap stocksPharmaceuticals
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in